Sanofi S.A. ADR buy Barclays PLC
Start price
27.03.23
/
50%
€49.40
Target price
27.03.24
-
Performance (%)
-7.69%
End price
28.03.24
€45.60
Summary
This prediction ended on 28.03.24 with a price of €45.60. With a performance of -7.69%, the BUY prediction by Barclays_PLC finished with a loss. Barclays_PLC has a follow-up prediction for Sanofi S.A. ADR where he still thinks Sanofi S.A. ADR is a Buy. Dividends of €3.55 are taken into consideration when calculating the performance. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Sanofi S.A. ADR | 0.000% | 0.000% | -11.489% |
| iShares Core DAX® | 0.130% | 3.439% | 29.827% |
| iShares Nasdaq 100 | -0.443% | 4.555% | 8.195% |
| iShares Nikkei 225® | 0.350% | 0.350% | -1.205% |
| iShares S&P 500 | -0.203% | 3.724% | 6.183% |
Comments by Barclays_PLC for this prediction
In the thread Sanofi S.A. ADR diskutieren
Sanofi (NASDAQ: SNY) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating.
Ratings data for SNY provided by MarketBeat
In the thread Trading Sanofi S.A. ADR
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten